Steven Prestrelski - Net Worth and Insider Trading

Steven Prestrelski Net Worth

The estimated net worth of Steven Prestrelski is at least $3 Million dollars as of 2025-07-23. Steven Prestrelski is the Chief Scientific Officer of Xeris Biopharma Holdings Inc and owns about 569,780 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $3 Million. Details can be seen in Steven Prestrelski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Prestrelski has not made any transactions after 2022-02-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Steven Prestrelski

To

Steven Prestrelski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Prestrelski owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .

Click here to see the complete history of Steven Prestrelski’s form 4 insider trades.

Insider Ownership Summary of Steven Prestrelski

Ticker Company Transaction Date Type of Owner
XERS Xeris Biopharma Holdings Inc 2022-02-22 Chief Scientific Officer

Steven Prestrelski Latest Holdings Summary

Steven Prestrelski currently owns a total of 1 stock. Steven Prestrelski owns 569,780 shares of Xeris Biopharma Holdings Inc (XERS) as of February 22, 2022, with a value of $3 Million.

Latest Holdings of Steven Prestrelski

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XERS Xeris Biopharma Holdings Inc 2022-02-22 569,780 5.06 2,880,238

Holding Weightings of Steven Prestrelski


Steven Prestrelski Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Prestrelski has made a total of 4 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the sale of 11,228 shares on February 22, 2022, which brought Steven Prestrelski around $27,172.

Insider Trading History of Steven Prestrelski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Prestrelski Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steven Prestrelski Ownership Network

Ownership Network List of Steven Prestrelski

No Data

Ownership Network Relation of Steven Prestrelski

Insider Network Chart


Steven Prestrelski Owned Company Details

What does Xeris Biopharma Holdings Inc do?

Who are the key executives at Xeris Biopharma Holdings Inc?

Steven Prestrelski is the Chief Scientific Officer of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include See Remarks Beth Hecht , Chief Financial Officer Steven Pieper , and See Remarks Shannon John Patrick Jr .

Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary

Over the past 18 months, Steven Prestrelski made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 18,700 shares made by John P. Schmid , a net sale of 40,000 shares made by Beth Hecht , and a net purchase of 25,000 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 40,000 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 43,700 shares were bought by its insiders, resulting in a net purchase of 3,700 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xeris Biopharma Holdings Inc Insider Transactions

No Available Data

Steven Prestrelski Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Prestrelski. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Steven Prestrelski's mailing address is: Chicago Il 60601.